Download Bridgitte Shen Lee, OD joins Guardion Health Sciences Medical

FOR IMMEDIATE RELEASE
Guardion Health Sciences, Inc.
15150 Avenue of Science, Ste. 200
San Diego, CA 92128
Ph 858.605.9055; Fax 858.630.5543
www.guardionhealth.com
Bridgitte Shen Lee, OD joins Guardion Health Sciences Medical
Advisory Board
San Diego, California – May 3, 2016 – Guardion Health Sciences (GHS), a leading
provider of verifiable and validated solutions in the areas of Ocular Health, is delighted to
announce that Dr. Bridgitte Shen Lee has joined its Medical Advisory Board.
“We are delighted to welcome Dr. Shen Lee to our Advisory Board. As the first Doctor of
Optometry to join our team, we are excited to be able to collaborate on our strategy of
growth and engagement with the Optometric sector, both here in the USA and
internationally” said Michael Favish, CEO of GHS.
Dr. Shen Lee is the cofounder of Vision Optique, an innovative high-end optical,
advanced contact lens practice, and comprehensive ocular health center, based in
Houston TX. In addition, Dr. Shen Lee is the founder of iTravelCE, a unique ‘destination
education’ company which provides a bridge between the Asian and American/European
optical industries. Her focus on specialty lens technologies, anti-aging eye care, ocular
aesthetics, and long term preventive ocular care, along with her biculturalism and
understanding of the Asian eye care market, together form a highly valuable skill set.
“As well as our commitment to American eye care, it is our intention to grow our footprint
internationally, particularly in the Asian markets. With her extensive experience in
product launch, business development, and clinical education, Dr. Shen Lee will make a
great addition to our team of highly respected Advisors.
We look forward to
collaborating with her to increase the understanding of the importance of the Macular
Pigment, particularly as it relates to the growing prevalence of high energy visible light
exposure” added Mr. Favish.
About Guardion Health Sciences, Inc.
Guardion Health Sciences, Inc. is a specialty health sciences company that develops,
formulates and distributes condition-specific medical foods with an initial medical food
product that addresses a depleted macular protective pigment, which is a known risk
factor for causing age-related macular degeneration (“AMD”), as well as computer vision
syndrome (“CVS”). Guardion Health Sciences, Inc. has also developed a proprietary
medical device that accurately measures the macular pigment density.
Guardion Health Sciences, Inc. currently develops and distributes a line of medical foods
that restores the macular protective pigment to address AMD and CVS under the brand
name Lumega-Z®. Guardion Health Sciences, Inc. is using its own proprietary patentpending technology embodied in a medical device called the MapcatSF™ that measures
the macular pigment. The MapcatSF™ is a patent-pending, non-mydriatic, non-invasive
device that accurately measures the macular protective pigment density, thereby
creating an evidence-based protocol that is shared with the patient
###